NL7207414A - - Google Patents
Info
- Publication number
- NL7207414A NL7207414A NL7207414A NL7207414A NL7207414A NL 7207414 A NL7207414 A NL 7207414A NL 7207414 A NL7207414 A NL 7207414A NL 7207414 A NL7207414 A NL 7207414A NL 7207414 A NL7207414 A NL 7207414A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/006—Ketals at position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7119711A FR2139708B1 (enExample) | 1971-06-01 | 1971-06-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL7207414A true NL7207414A (enExample) | 1972-12-05 |
Family
ID=9077892
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL7207414A NL7207414A (enExample) | 1971-06-01 | 1972-06-01 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US3770725A (enExample) |
| JP (1) | JPS5647200B1 (enExample) |
| BE (1) | BE784192A (enExample) |
| CA (1) | CA967149A (enExample) |
| DE (1) | DE2226552C3 (enExample) |
| FR (1) | FR2139708B1 (enExample) |
| GB (1) | GB1365229A (enExample) |
| NL (1) | NL7207414A (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001275163A1 (en) * | 2000-06-02 | 2001-12-17 | Massachusetts Institute Of Technology | A tumor suppressor pathway in c. elegans |
| DE102007027635A1 (de) | 2007-06-12 | 2008-12-18 | Bayer Schering Pharma Aktiengesellschaft | 17ß-Cyano-19-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel |
| DE102007027636A1 (de) * | 2007-06-12 | 2008-12-18 | Bayer Schering Pharma Aktiengesellschaft | 17ß-Cyano-18a-homo-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel |
| DE102007027637A1 (de) * | 2007-06-12 | 2008-12-18 | Bayer Schering Pharma Aktiengesellschaft | 17ß-Cyano-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel |
| WO2010066354A1 (de) * | 2008-12-12 | 2010-06-17 | Bayer Schering Pharma Aktiengesellschaft | VERWENDUNG VON 17β-CYANO-18A-HOMO-19-NOR-ANDROST-4-EN-DERIVATEN ZUR HERSTELLUNG EINES ARZNEIMITTELS IN DEPOT-FORM ZUR PARENTERALEN ANWENDUNG SOWIE DEPOT-ARZNEIMITTEL ENTHALTEND 17β-CYANO-18A-HOMO-19-NOR-ANDROST-4-EN-DERIVATE ZUR PARENTERALEN ANWENDUNG |
| WO2010066349A1 (de) * | 2008-12-12 | 2010-06-17 | Bayer Schering Pharma Aktiengesellschaft | Verwendung von 17beta-cyano-19-androst-4-en-derivaten zur herstellung eines arzneimittels in depot-form zur parenteralen anwendung sowie depot-arzneimittel enthaltend 17beta-cyano-19-androst-4-en-derivate zur parenteralen anwendung |
| WO2010066355A1 (de) * | 2008-12-12 | 2010-06-17 | Bayer Schering Pharma Aktiengesellschaft | VERWENDUNG VON 17β- CYANO-19-NOR-ANDROST-4-EN-DERIVATEN ZUR HERSTELLUNG EINES ARZNEIMITTELS IN DEPOT-FORM ZUR PARENTERALEN ANWENDUNG SOWIE DEPOT-ARZNEIMITTEL ENTHALTEND 17β-CYANO-19-NOR-ANDROST-4-EN-DERIVATE ZUR PARENTERALEN ANWENDUNG |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2806030A (en) * | 1954-03-20 | 1957-09-10 | Syntex Sa | Cyclopentanophenanthrene derivatives and process for the preparation thereof |
-
1971
- 1971-06-01 FR FR7119711A patent/FR2139708B1/fr not_active Expired
-
1972
- 1972-05-31 BE BE784192A patent/BE784192A/xx not_active IP Right Cessation
- 1972-05-31 CA CA143,806A patent/CA967149A/en not_active Expired
- 1972-05-31 DE DE2226552A patent/DE2226552C3/de not_active Expired
- 1972-05-31 US US00258324A patent/US3770725A/en not_active Expired - Lifetime
- 1972-06-01 GB GB2557672A patent/GB1365229A/en not_active Expired
- 1972-06-01 JP JP5389172A patent/JPS5647200B1/ja active Pending
- 1972-06-01 NL NL7207414A patent/NL7207414A/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| GB1365229A (en) | 1974-08-29 |
| DE2226552C3 (de) | 1982-05-19 |
| JPS5647200B1 (enExample) | 1981-11-07 |
| US3770725A (en) | 1973-11-06 |
| DE2226552A1 (de) | 1973-01-04 |
| CA967149A (en) | 1975-05-06 |
| FR2139708B1 (enExample) | 1974-08-23 |
| DE2226552B2 (de) | 1981-07-30 |
| BE784192A (fr) | 1972-11-30 |
| FR2139708A1 (enExample) | 1973-01-12 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BA | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| BI | The patent application has been withdrawn |